tritace comp 2.5 mg12.5 mg
sanofi israel ltd - hydrochlorothiazide; ramipril - tablets - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension.tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.
tritace comp 5 mg25 mg
sanofi israel ltd - hydrochlorothiazide; ramipril - tablets - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension.tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.
tavanic 500 mg solution for i.v. infusion
sanofi - aventis israel ltd - levofloxacin as hemihydrate - solution for infusion - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.
frisium
sanofi israel ltd - clobazam - tablets - clobazam 10 mg - clobazam - clobazam - frisium is a 1,5-benzodiazepine indicated for the short-term relief (2 – 4 weeks) only of anxiety in adult patients that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short term psychosomatic, organic or psychotic illness.the use of frisium to treat short-term “mild” anxiety is inappropriate and unsuitable.
imovane
sanofi israel ltd - zopiclone - film coated tablets - zopiclone 7.5 mg - zopiclone - zopiclone - imovane is indicated for the short-term treatment of insomnia in adults
ambien cr 6.25 mg
sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 6.25 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
ambien cr 12.5 mg
sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 12.5 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
rilutek
sanofi israel ltd - riluzole - film coated tablets - riluzole 50 mg - riluzole - riluzole - rilutek is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (als).
depakine 200mg/ml oral solution
sanofi aventis-egypt - syrup - 200 mg/ml
depakine chrono 500mg scored prolonged release f.c.tab.
sanofi aventis-egypt - tablet - 500 mg